Placebo usage in clinical trials of lifesaving drugs
Miller, B.L.
Progress in Clinical and Biological Research 38: 263-274
1980
ISSN/ISBN: 0361-7742 PMID: 7384132 Document Number: 155425
Document emailed within 1 workday
Related Documents
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274Kemény, L.; Brodszky, V.; Kárpáti, K.án.; Gulácsi, L.ás.ó 2006: The role of biological drugs in the treatment of psoriasis, results from 9 randomized placebo-controlled trials Orvosi Hetilap 147(21): 981-990
Srisurapanont, M.; Maneeton, N. 1999: Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials Journal of the Medical Association of Thailand 82(4): 341-346
Leber, P. 1986: The placebo control in clinical trials (a view from the FDA) Psychopharmacology Bulletin 22(1): 30-32
Wilde, H.; Phaosavasdi, S.; Pruksapong, C.; Tannirandorn, Y.; Taneepanichskul, S. 1999: Ethics of using controls and placebo in clinical trials Journal of the Medical Association of Thailand 82(6): 632-635
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Bystritsky, A.; Waikar, S.V. 1994: Inert placebo versus active medication. Patient blindability in clinical pharmacological trials Journal of Nervous and Mental Disease 182(9): 485-487
Murphy, J.; Coxon, R.; Sharpe, D.N. 1985: Practical aspects of clinical trials: a review of a randomized, placebo-controlled study in patients with heart failure Heart and Lung: the Journal of Critical Care 14(1): 95-100
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Berber, A.; Del-Rio-Navarro, B. 2001: Compilation and meta-analysis of randomized placebo-controlled clinical trials on the prevention of respiratory tract infections in children using immunostimulants Journal of Investigational Allergology and Clinical Immunology 11(4): 235-246
Lal, A.; Sharma, M.L. 1992: An assessment of clinical trials with drugs Indian Journal of Physiology and Pharmacology 36(2): 143-145
Hoeger, K.; Davidson, K.; Kochman, L.; Cherry, T.; Kopin, L.; Guzick, D.S. 2008: The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials Journal of Clinical Endocrinology and Metabolism 93(11): 4299-4306
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7
Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297
Bartus, R.T.; Dean, R.L.; Beer, B. 1983: An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans Psychopharmacology Bulletin 19(2): 168-184
Shamsudin, N.; Fleischer, A.B. 2010: Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journals Journal of Drugs in Dermatology: Jdd 9(10): 1221-1226